Core Insights - Envista Holdings Corp. (NYSE:NVST) experienced a significant stock price increase of 23.4% week-on-week, reaching a nearly three-year high, driven by strong earnings performance and a return to profitability [1][3] Financial Performance - The company reported a net income of $47 million for the previous year, a turnaround from a net loss of $1.1 billion in 2024 [3] - Year-on-year sales increased by 8% to $2.7 billion, up from $2.5 billion [3] - In Q4, net profit surged by 2,642% to $32.9 million from $1.2 million in the same quarter the previous year [3] - Q4 sales grew by 15% to $750.6 million, compared to $652.9 million in the same period last year [3] Strategic Focus - The CEO emphasized a disciplined focus on growth, operations, and employee development, highlighting positive growth across all major businesses and geographies [4] - The company returned $166 million to shareholders through share repurchases [4] Future Outlook - For the current year, Envista aims to grow core sales by 2 to 4% and expects adjusted EBITDA to increase by 7 to 13% [5] - Adjusted diluted earnings per share are projected to be between $1.35 and $1.45 [5]

Core Viewpoint - Under Armour Inc. (NYSE: UAA) experienced a significant stock surge of 22.5% week-on-week, driven by increased price targets from investment firms, despite reporting disappointing earnings for Q3 of fiscal year 2026 [1]. Group 1: Price Target Adjustments - Barclays raised its price target for Under Armour to $8 from $6, while Truist Securities increased its target to $8 from $5 [2]. - Barclays maintains a "neutral" stance on the stock, and Truist holds a "hold" recommendation [3]. Group 2: Earnings Performance - Under Armour reported a net loss of $430.8 million for Q3, a significant decline from a net income of $1.2 million in the same period the previous year [3]. - Net revenues fell by 7% to $1.3 billion compared to $1.4 billion year-on-year [4]. - For the nine-month period, the company's net loss widened by 238% to $452 million from $133.8 million in the same period a year earlier, with net revenues decreasing by 4.5% to $3.8 billion from $3.98 billion year-on-year [4].

Trade Desk Inc (NASDAQ:TTD) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. On February 2, Cathie Wood’s ARK ETF divested a significant portion of its holdings in Trade Desk Inc (TTD), offloading 1,931,578 shares for nearly $58.6 million. Earlier in the month, Wells Fargo maintained an Equal Weight rating on the stock with a price target of $42. In a research note, Wells Fargo said the sudden resignation of the company’s chief financial officer is a sign of “continued fundamental and narrat ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best stocks under $3 to invest in. On January 9, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) announced that it expects to achieve its previously disclosed full-year 2025 revenue guidance range of $250 to $300 million in the first full calendar year of Amtagvi sales. The company also expects Amtagvi, Iovance’s treatment regimen for advanced melanoma, will have up to $1 billion in peak sales potential. Iovance Biotherapeutics (IOVA) Gives Update on Rev ...

New Gold Inc. (NYSEAMERICAN:NGD) is one of the most undervalued Canadian stocks to buy according to hedge funds. On January 26, Scotiabank analyst Eric Winmill raised the firm’s price target on New Gold to $12.75 from $10.50 with an Outperform rating. The firm is updating targets across its Gold & Precious Minerals coverage, driven by increased forecasts for gold and silver. These higher projections are supported by economic and geopolitical uncertainty, as well as continued strong buying from central bank ...

Pelican Bay Capital Management (PBCM), an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. PBCM Concentrated Value Strategy returned 8.5% in the quarter, compared to a 3.8% return for the Russell 1000 Value Index. The robust performance of AI-related stocks and commodities exposure drove the Strategy’s performance in the quarter. For the full year, the Strategy returned 20.6% compared to 15.9% for the Index. The firm seeks to inve ...

Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% (Institutional Shares) in the quarter, compared to a 11.92% gain for the Russell 3000 Health Care Index (benchmark) and a 2.40% gain for the Russell 3000 Index (the Index). The Fund returned 10.28% for the full year, compared to 14.56% and 17.15% gains for the indexes, respectively. Strong stock selection in biotechnol ...

We recently published 10 Big Names, Bigger Losses. Strategy Inc. (NASDAQ:MSTR) was one of the worst performers on Thursday. Strategy saw its share prices drop to a new 52-week low, as investors unloaded portfolios following Bitcoin’s drop to the $62,000 level, coupled with a disappointing earnings performance in both the full year and fourth quarter of 2025. At intra-day trading, the stock fell to its lowest price of $104.17 before paring losses to end the day down by 17.12 percent at $106.99 apiece. St ...

Costco Wholesale Corporation (NASDAQ:COST) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. Mizuho Raises Costco (COST) Target as Membership Trends Rebound Niloo / Shutterstock.com On February 3, Mizuho lifted its price target on Costco Wholesale Corporation (NASDAQ:COST) to $1,065 from $1,000 and kept its Outperform rating in place. The firm expects the stock to keep finding support through the year as membership growth picks back up and the pace of consumer spending cools to more ...

Diamond Hill Capital, an investment management company, released its “Small Cap Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fourth quarter posted another period of favorable gains for equity markets, with the Russell 2000 Index returning 2.19%, roughly in line with the Russell 1000 Index’s 2.41% gain. Health care (+18.6%) emerged as the best-performing sector in the Russell 2000 Index. Heightened uncertainty and geopolitical risks contributed to a mixed ma ...